Cargando…
Gradeability and Reproducibility of Geographic Atrophy Measurement in GATHER-1, a Phase II/III Randomized Interventional Trial
OBJECTIVE: To validate GATHER-1 inclusion criteria and the study’s primary anatomic end point by assessing the reproducibility of geographic atrophy (GA) measurements and factors that affect reproducibility. DESIGN: Post hoc analysis of phase II/III clinical trial. SUBJECTS: All 286 participants inc...
Autores principales: | Li, Angela S., Myers, Justin, Stinnett, Sandra S., Grewal, Dilraj S., Jaffe, Glenn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587635/ https://www.ncbi.nlm.nih.gov/pubmed/37868797 http://dx.doi.org/10.1016/j.xops.2023.100383 |
Ejemplares similares
-
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
por: Patel, Sunil S., et al.
Publicado: (2023) -
Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
por: Patel, Sunil S., et al.
Publicado: (2023) -
Repeatability of Peripapillary OCT Angiography in Neurodegenerative Disease
por: Ma, Justin P., et al.
Publicado: (2021) -
The Role of the Complement Pathway in Clinical Progression of Geographic Atrophy: Analysis of the Phase III Chroma and Spectri Trials
por: Edmonds, Rose, et al.
Publicado: (2023) -
Using Geographic Information for Disease Surveillance at Mass Gatherings
por: Blatt, Amy J.
Publicado: (2014)